Skip to main content
. 2019 Nov 14;19(1):424–430. doi: 10.3892/ol.2019.11099

Figure 5.

Figure 5.

ICER scatter plot reflecting the variation and concentration of ICER values following probabilistic sensitivity analysis. BEV, bevacizumab; TMZ, temozolomide; WTP, willingness to pay; ICER, incremental cost-effectiveness ratio.